Corresponding our data CCNG2 was identified as direct target of miR-1246 in oral squamous cell carcinoma [50], laryngeal squamous cell carcinoma [51], ovarian cancer [52], pancreatic carcinoma [53], colorectal cancer [54] and breast cancer [38]. Here, CCNG2 is linked to breast cancer.